Ann Tsukamoto

Dr. Ann Tsukamoto (born July 6, 1952 California, United States) is an inventor, scientist and stem cell researcher. In 1991 Tsukamoto and her colleagues Charles Baum, Irv Weissman, Ashley Buckle, and Bruno Peault became the first researchers to identify and isolate blood-forming stem cells.[1][2]

Ann Tsukamoto received her undergraduate from University of California, San Diego and later received her Ph.D.from University of California, Los Angeles.[3] She did her post doctorate research at the University of California, San Francisco where she worked along side Nobel Laureate Harold Varmus. Together they created a transgenic model for breast cancer [3]

Tsukamoto was employed at SyStemix, a biotech company, from 1989-1997 where she was connected with isolation of the Hematopoietic stem cell. [3] In 1998, Ann joined StemCells, Inc. where she became a leader in overseeing the isolation of human liver and neural stem cells to a variety of different diseases. When she joined the company, she was one of the few first world class researchers who were focused on the development and discovery of human stem cells. She has received multiple leadership roles while employed with Stem Cells, Inc.

Tsukamoto holds 12 patents related to her research.[4]

Isolation of a candidate human hematopoietic stem-cell population

References

  1. ↑ "A Patient talks about being treated in a landmark breast cancer clinical trial more than a dozen years ago". Institute for Stem Cell Biology
    and Regenerative Medicine    . Retrieved 2018-10-06.
  2. ↑ bellis, mary. "Ann Tsukamoto - The Stem Cell Research of Ann Tsukamoto". theinventors.org. Retrieved 2018-03-30.
  3. 1 2 3 "BIOS 206 Brief Speaker Biographies:" (PDF). Stanford.edu.
  4. ↑ "Ann Tsukamoto Inventions, Patents and Patent Applications - Justia Patents Search". patents.justia.com. Retrieved 2018-03-31.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.